Tuesday 8 June 2021
Investor Ideas #Potcasts 573, #Cannabis News and #Stocks on the Move; (CSE: $DELC.C) (OTCQB: $DELCF), (TSXV: $MUSH.V), (CSE: $CURA.C) (OTCQX: $CURLF), (TSXV: $KHRN.V) (OTCQX: $KHRNF)
Investor Ideas #Potcasts
573, #Cannabis News and #Stocks on the Move; (CSE: $DELC.C) (OTCQB: $DELCF),
(TSXV: $MUSH.V), (CSE: $CURA.C) (OTCQX: $CURLF), (TSXV: $KHRN.V) (OTCQX: $KHRNF)
Delta, Kelowna, BC, June 8, 2021 (Investorideas.com Newswire) www.Investorideas.com,
a global news source covering leading sectors including marijuana and hemp
stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/060821-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/06081DELC-MUSH-CURA-KHRN.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few private and public company announcements.
Delic Holdings Inc. (CSE:
DELC) (OTCQB:
DELCF), a leading psychedelic wellness platform has
signed a definitive agreement to acquire Ketamine Infusion Centers LLC. KIC is a
limited liability corporation formed under the laws of Arizona, which owns and
operates two ketamine infusion treatment clinics, one in Phoenix, Arizona and
the other in Bakersfield, California.
Supported
by clinical trials and peer reviewed studies, ketamine infusions have emerged
as a promising treatment option for chronic diseases and pain disorders. The
successful completion of the transaction will bring a physical retail footprint
to the DELIC ecosystem where it can leverage its IP, product development and
audience capture through its various leading media properties.
Transaction
Highlights
● The Transaction establishes DELIC as a
diversified psychedelics organization. KIC has been
growing steadily with revenues in excess
of USD$1.5 million since 2019
● KIC will be one of the largest ketamine
clinics, pending recently announced expansion. KIC will double
its footprint to four (4) physical locations in California and Arizona
● KIC will be strategically positioned to
leverage DELIC platform and brand: DELIC expects to
drive patients to KIC through its media platform and become a national leader
● Established history of providing ketamine
infusion services. The management team at KIC has been in business for 3 years expanding
services throughout the United States
● Management expertise. The
acquisition of KIC will add a team of 6 medical professionals and employees bringing a wealth of
industry experience
and knowledge to DELIC
Matt
Stang, Founder and CEO of DELIC commented, "We publicly listed DELIC with
the intent of buying cash-flowing, scalable companies and that is exactly what
KIC represents. We are focused on making psychedelic wellness truly accessible,
and this is a huge development in the realization of that vision."
Sonny
Diaz, Co-Founder of KIC stated, "We were thrilled to be joining the DELIC
platform as we feel their patient acquisition strategy - using DELIC's media
platform to drive patients - is a game changer for scaling our clinics and
expanding patient access. With a history of profitability and a management team
with decades of experience in the health sector and successful exits of over
two dozen clinics and hospitals, KIC's extensive background in operating
clinics and hospitals will enable DELIC to be the leader in legal psychedelic
treatment clinics.
By
acquiring KIC, DELIC expands from its hub of psychedelic education, media, and
information properties and licensed lab and IP company (CBDV) to the ability to
provide patients with psychedelic therapy. DELIC is uniquely positioned to
bring digital awareness to its various holdings under the DELIC umbrella, and
drive online users to brick and mortar clinics.
Over
the last 3 years, the team at KIC has expanded from Arizona to California,
while overseeing 4,000 treatments delivered to date, and generating over
USD$1.5MM in revenue. KIC will operate under the DELIC umbrella, under the
direction and guidance of Dr. Christopher Ray, Sonny Diaz, Rogelio Monzon, and
Ganesh Acharya.
The Good Shroom Co
Inc. (TSXV:
MUSH), a Quebec based company that manufactures functional
beverages under its two brands: Teonan® and Velada™, has
signed an agreement with Mr. Rob Leichman, President of The
Lyric Group, LLC, a leading business development consultant with a particular
expertise in consumer-packaged goods distribution. TGSC has also initiated a
podcast marketing campaign with AdvertiseCast to continue expanding their
e-commerce presence throughout North America.
Lyric Group, LLC to
Lead US Distribution.
The
Lyric Group, LLC launches emerging and established food and beverage brands
onto retail shelves throughout the US. Mr. Leichman and TGSC have come to an
agreement whereby he will lead TGSC's US distribution starting in key states by
utilizing his varied list of established buyer, distributor and merchandizing
relationships across multiple channels to launch the Teonan products. The
Tri-State area (New York. New Jersey and Connecticut) will be the primary focus
and used along with the pacific northwest and northern California.
The
Lyric Group will manage strategy execution from logistics to product placement on
retail shelves alongside the TGSC operations team. TGSC expects to launch its
products in the fall of 2021.
E-commerce
Expansion: Podcast
Over
100 million Americans have listened to a podcast in the last month and the
projected amount of podcast ad spend by the end of the year is over $1 billion.
Additionally, a survey of 300,000 listeners found that 63% of people bought
something a host had promoted on their show.
In
order to continue expanding its e-commerce presence TGSC has initiated
Advertise Cast, one of the premier US podcast advertising networks to manage
its podcast marketing. Advertise Cast and TGSC have identified strategic
podcasters based on the quantity of listeners versus their demographics and
will be marketing its products through podcaster reviews and targeted ads in
various forms. Through this agreement, the Company will gain exposure to a
targeted portion of Advertise Casts's monthly listener reach of over
40,000,000. *
Curaleaf
Holdings, Inc. (CSE:
CURA) (OTCQX:
CURLF), a leading international provider of consumer
products in cannabis, announced a
first-of-its-kind strategic partnership between its Select brand and legendary
music and culture authority Rolling
Stone. Together, the leading lifestyle brand in cannabis joins the most
prominent voice in music and pop culture to celebrate the symbiotic
relationship between music and cannabis. The long term partnership leverages
Select's resources and experience creating progressive, industry-leading
cannabis products alongside Rolling Stone, whose DNA lives at the intersection
of music's past, present and future.
The new line of co-branded Rolling
Stone by Select products will include two product formats to start, including
Select's first-ever pre-roll, as well as "The Cliq," Select's newest
proprietary pod system. Both formats will feature three strains and flavor
profiles hand-selected by Rolling Stone to celebrate some of the most
well-known and genre-defining artists and sounds in music history. The line
includes a berry-forward "Overdrive" Sativa, complex and full-bodied
"Reverb" Indica, and a fruity and calming "Phaser" Hybrid.
"Part of my job at Curaleaf is
building brands people love. Select is a brand built around the relentless
pursuit of progress, and going to great lengths to create the best possible
experience for our consumer. This is a synergy we are honored to share with
Rolling Stone. They are known for having one of the most authentic and
discerning voices in modern journalism, and, as part of that, they've included
cannabis in their coverage for the past 50 years - something many other
publications are only just starting to do today. We're honored and thrilled
that the Rolling Stone team believes in our vision, our products and our people
to create and deliver the highest-quality cannabis products and experiences in
the industry," said Joe Bayern, CEO of Curaleaf.
"Music and Cannabis go hand in
hand," said Rolling Stone President and Chief Operating Officer Gus
Wenner. Rolling Stone has a legacy of celebrating this connection and a long
history of reporting on the fight to legalize cannabis. "We are thrilled
to have found a perfect partner in Curaleaf who gives us the opportunity to
design a product that elevates the music listening experience and celebrates
the deep connection between the two."
Select's commitment to enriching
communities and creating inclusive, meaningful experiences and Rolling Stone's
world class storytelling and culture-defining content inspired the inception of
a first-of-its-kind retail space opening in Las Vegas in 2022. Additional
details on the space will be released in the near future.
In Nevada, Rolling Stone by Select
products will be distributed through Select's wholesale partners and at
Curaleaf's owned dispensaries, including Acres by Curaleaf and Curaleaf Las
Vegas Boulevard. For more information about Select's portfolio of products or find
a dispensary near you that carries Select products, visit us at www.selectcannabis.com.
Khiron Life
Sciences Corp. (TSXV:
KHRN) (OTCQX:
KHRNF), a vertically integrated medical cannabis leader with
core operations in Latin America and Europe, announced the
receipt of the Company's largest ever shipment of EU-GMP certified medical
cannabis product for distribution and sale into the German market.
Recently,
Khiron's German distribution partner, Nimbus Health GmbH, received
approximately 36kg of Khiron 20/1 medical cannabis product, a THC-dominant
cannabis flower product which has been prescribed to patients in the UK since
July 2020. The new product increases the Company's German medical cannabis
offering, which now includes both THC-dominant and CBD-dominant Cannabis products. As a result of the shipment, the Company
expects to increase its European medical cannabis sales in the second quarter
of 2021.
"As
we launch another new product into Germany and more than triple our shipment
volumes, our European team continues to demonstrate strong execution and
leadership. In line with our Mission of improving patients' lives through
medical cannabis, we continue to expand our offering of EU-GMP
cannabinoid-based medicines. Simultaneously, we are developing additional
products based on our Colombian extracts, whose efficacy and safety are backed
by real-world evidence from over 20,000 prescriptions," comments Alvaro
Torres, CEO and Director.
Khiron's
European product portfolio now includes both THC-dominant and CBD-dominant
cannabis flower products available for sale in Germany and the UK, two of the
largest chronic pain markets in Europe. Over the coming months, the Company
plans to increase patient access by expanding its product offering and medical
education initiatives.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and that this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment.
Learn
more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investors can trade these stocks and
other ideas on our site using our list of top stock trading
apps
including Robinhood , Acorn, Stash and others.
To
hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The
Investorideas.com podcasts are also available on iTunes ( Apple Podcasts)
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google Play
Music and most audio platforms available.
Potcasts
is now a certified word mark Trademark on the blockchain through Cognate, Inc.
CM Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
publishes breaking stock news, third
party stock research , guest posts and original
articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and
IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor
Idea’s original branded content includes podcasts and columns : Crypto Corner , Play
by Play sports and stock news , Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast ,
Cleantech
and Climate Change , Exploring
Mining , Betting
on Gaming Stocks Podcast and
the AI
Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Breaking #CBD #Stock News - Link Reservations Inc/LinkResPet (OTC: $LRSV) @res_pet to Start Selling CBD Products on Amazon US ( $AMZN)
Breaking #CBD #Stock News - Link Reservations Inc/LinkResPet (OTC:
$LRSV) @res_pet to Start
Selling CBD Products on Amazon US ( $AMZN)
London, UK– June 8, 2021 - Breaking CBD stock news from Investorideas.com Newswire- Link
Reservations Inc. (OTC: LRSV),
a provider of medicinal mushroom and cannabidiol (CBD) wellness products for
both humans and pets, announces it intends start selling its LinkResPet and
DailyLifeCBD products on Amazon.com. The Company would stock its LinkResPet cat
and dog CBD products as well as its DailyLifeCBD mushroom-infused Immune
product, on the online platform.
Read this news,
featuring LRSV in full at https://www.investorideas.com/news/2021/cannabis/06081CBD-LRSV-AMZN.asp
Rene
Lauritsen, Link Reservations Inc CEO commented: “This is something we are very
excited about as it will open up our retail avenues to include more sources of
revenue. Amazon has become ever-present in our society, and a great first point
of purchase for anyone looking for CBD, hemp or mushroom products. By selling
on Amazon, we would be able to reach a larger audience looking for wellness
solutions and so increase our revenue. Our intention is to initially stock our
products on Amazon US but we hope to also operate on the UK based platform
(amazon.co.uk) at a later date.”
LinkResPet’s
products consist of CBD tinctures for dogs and cats. While DailyLifeCBD has a
functional mushroom and CBD range of products including its DailyLifeCBD Immune
tincture, as well as other CBD products in the pipeline. All products are made
with the highest quality hemp oil and are lab tested, THC and GMO free. The
hemp oil used in LRSV products comes from organically
grown certified U.S. and European hemp. The Company ensures that its
products undergo a rigorous process of quality control and testing using the
latest scientific methods.
For
more information about LinkResPet or to purchase CBD products for pets, please
visit www.linkrespet.com or
follow them on Twitter on @res_pet
For
more information about DailyLifeCBD, the Company’s range of CBD and mushroom
product for people, please visit: https://dailylifecbd.com/
About Link Reservations Inc.
Link Reservations Inc is a CBD and wellness product provider dedicated to
improving the health and life conditions of both people and pets worldwide. Its
trades through its two brands; LinkResPet and DailyLifeCBD. LinkResPet develops
and markets hemp-based CBD products for cats, dogs and horses. DailyLifeCBD
provides everyday hemp based CBD wellness and mushroom products for people. The
Company has operations in both the US and Europe.
Forward-Looking Statements &
Disclaimers:
The information in this Press Release includes certain
"forward-looking" statements within the meaning of the Safe Harbor
provisions of Federal Securities Laws, as that term is defined in section 27a
of the United States Securities Act of 1933, as amended, and section 21e of the
United States Securities Exchange Act of 1934, as amended. Statements in this
document, which are not purely historical, are forward-looking statements and
include any statements regarding beliefs, plans, expectations or intentions regarding
the future. Investors are cautioned that such statements are based upon
assumptions that in the future may prove not to have been accurate and are
subject to significant risks and uncertainties, including the future financial
performance of the Company. Although the Company believes that the expectations
reflected in its forward-looking statements are reasonable, it can give no
assurance that such expectations or any of its forward-looking statements will
prove to be correct. Readers are cautioned not to place undue reliance on these
forward-looking statements that speak only as of the date of this release, and
the Company undertakes no obligation to update publicly any forward-looking
statements to reflect new information, events, or circumstances after the date
of this release except as required by law.
Link Reservations Inc
400 Thames Valley Park Drive
Reading Berkshire RG6 1 PT
United Kingdom
Phone: +44 330 808 0897
Paid News -Disclaimer/Disclosure: Investorideas.com is a digital
publisher of third party sourced news, articles and equity research as well as
creates original content, including video, interviews and articles. Original
content created by investorideas is protected by copyright laws other than
syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. Disclosure : this news release featuring LRSV is a paid for news
release on Investorideas.com More disclaimer
info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing
your news release and our other news services on the Investorideas.com
newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Please
read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
About Investorideas.com
https://www.investorideas.com/About/
Sign up for free stock news alerts at Investorideas.com
https://www.investorideas.com/Resources/Newsletter.asp
Investors can trade these stocks and other ideas on our
site using our list
of top stock trading apps including Robinhood,
Acorn, Stash and others.
Get
more Cannabis Stock
Investor Ideas -
news, articles, podcasts and stock directories
Monday 7 June 2021
Friday 4 June 2021
Investor Ideas #Potcasts 572, #Cannabis News and #Stocks on the Move (CSE: $PLTH.C) (OTCQB: $PLNHF), (NASDAQ: $CRON) (TSX: $CRON.TO), (TSX: $VLNS.TO) (OTCQX: $VLNCF)
Investor Ideas #Potcasts
572, #Cannabis News and #Stocks on the Move (CSE: $PLTH.C) (OTCQB: $PLNHF),
(NASDAQ: $CRON) (TSX: $CRON.TO), (TSX: $VLNS.TO) (OTCQX: $VLNCF)
Delta, Kelowna, BC, June 4, 2021 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/060421-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/06041PLTH-CRON-VLNS.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few private and public company announcements.
Planet 13 Holdings
Inc. (CSE:PLTH) (OTCQB:PLNHF), a leading vertically-integrated
Nevada cannabis company, welcomes recently passed bill 341 allowing
existing licensed dispensaries to operate a consumption lounge co-located with
the dispensary. Planet 13 has reserved an expansive dedicated space within the
Las Vegas SuperStore for a consumption lounge which it will look to get built
as soon as possible.
"We
are thrilled that after the long wait, Nevada will finally be home to
consumption lounges. We've long believed that tourists needed a safe, legal,
and enjoyable place to consume cannabis and have been planning for a
consumption lounge at the SuperStore since the bill was originally proposed two
years ago," said Bob Groesbeck Co-CEO of Planet 13. "Our SuperStore
is one of the only dispensaries with the space on site and the proximity to the
Las Vegas Strip to create a truly Vegas style club. As with the rest of our
dispensary we look forward to setting the bar and showing the industry what is
possible when your goal is to Out Vegas, Vegas."
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), an innovative global cannabinoid
company, and Ginkgo Bioworks, Inc. (“Ginkgo”), which is building the leading
horizontal platform for cell programming, today announced an amended collaboration and
license agreement (the “Amended Agreement”) that will enable the companies to
accelerate the commercialization of cultured cannabinoids at scale.
The
Amended Agreement with Ginkgo will enable Cronos Group to commercialize
products using cultured cannabinoids ahead of reaching the originally stated
productivity targets, while maintaining the incentives to continue to develop
towards and achieve the previously agreed upon efficiency and cost goals. This
approach is expected to facilitate Cronos Group’s cultured cannabinoid products
being first to market in Canada, which will drive significant market knowledge
and consumer insights that are expected to help deliver future novel and
innovative consumer-driven products. Cronos Group expects that the final
productivity target for CBG will be achieved prior to September 2021, as
previously announced.
The
Amended Agreement follows the receipt of Cronos Fermentation’s processing
license in April 2021, and most recently the receipt of its CRA license. With
the Amended Agreement and both licenses in hand, Cronos Fermentation commenced
commercial production of CBG today. Cronos Group is prioritizing rare cannabinoids,
such as CBG, and plans to sequence commercial production and subsequent product
launches based on this approach.
“Beginning
commercial production demonstrates the significant progress underway with our
Ginkgo partnership and the competitive benefits we see in being first to market
with innovative consumer products,” said Kurt Schmidt, President and Chief
Executive Officer of Cronos Group. “Cannabis holds many unique compounds with a
wide range of potential use cases and benefits. By leveraging Ginkgo’s research
platform and our fermentation manufacturing capabilities, we believe we have
disruptive technology that can deliver rare cannabinoids at scale and elevate
the consumer experience.”
“Biological
manufacturing is unlocking access to important cannabinoids that can be scaled
up and produced reliably, consistently and economically,” said, Jason Kelly,
Chief Executive Officer and Co-Founder of Ginkgo. “We look forward to
continuing our work with Cronos to facilitate innovation bringing this powerful
technology to the cannabis industry.”
Goodleaf
Company,
the leading cannabis brand in South Africa, has merged with Highlands Investments, formerly Canopy Growth Africa, in a deal
valued at almost $50million. The transaction has resulted in the largest
vertically integrated cannabis operation in Africa, with an investment in
excess of $25million to date.
"We are delighted to conclude
this merger, and in doing so create Africa's first truly seed-to-sale
offering," says Warren Schewitz, Founder and CEO of Goodleaf. "It's
always been our intention to create a world-class global brand, and as we scale,
access to high-quality supply is essential, which Highlands affords."
"This transaction brings
together two of the biggest cannabis players in Africa," says Jody
Aufrichtig, Founder - Highlands Investments. "Highlands is the first ISO
22000 grade cannabis producer in Africa, the quality of our product is
world-class, this combined offering will enable us to make significant inroads
globally, because we can compete both on quality and price."
Goodleaf, a premium CBD brand, has
commercialized a portfolio of 30 products in multiple categories, and has well
established distribution lines through retail stores, online, wholesale, and
coffee shops in South Africa. Goodleaf's products will soon be exported to
retailers in Asia and Europe.
"Consumers are demanding
quality products with a known origin," says Schewitz. "Lesotho's
pristine growing environment, combined with Highlands commitment to GACP
("Good Agricultural and Collection Practices") and ISO 22000
standards, ensures access to a reliable, certified high-quality supply."
Highlands has a track record of
producing premium CBD flower. In April 2021 it concluded its fourth harvest in
Lesotho, the outdoor harvest yielded almost six tonnes of premium cannabis; a
significant portion is destined for the European medical cannabis market.
Highlands will continue to supply bulk CBD and THC flower, distillate and
isolate to global medical and wellness markets.
"This is a transformational
transaction for Goodleaf as we have diversified our business into a fully
seed-to-sale offering, strengthening our leadership position in the South
African cannabis market. It provides a low cost production base for our product
range as we expand into global markets," Schewitz concludes.
Under terms of the transaction,
Highlands' shareholders will have 35% shareholding in the merged entity, with
Goodleaf being the majority shareholder at 65%. The merged entity will continue
to trade as Goodleaf and Highlands Investments.
The
Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF), a leading manufacturer of cannabis products, announced that it has launched several new
products in partnership with Verse Cannabis in the flower, pre-roll,
concentrates, and edibles categories. With the continued launch of
next-generation, high quality cannabis products across various categories,
Valens continues to partner with Verse to further its mission to provide all
Canadians with best-in-class formulations in innovative formats at value price
points.
The new products launched under the
Verse Originals line include BC God Bud Flower, Dreamweaver Pre-Rolls and Amp
Pre-Roll, in addition to the Double Chocolate Brownie – one of the first
confectionery products of its kind to hit the Canadian recreational market.
Additionally, the newly launched Killer Kush Live Terp Vape Cartridge and Hash
will be available as part of the Verse Concentrates offering. The launch of
these new products marks Valens' entry into the flower and pre-roll categories,
an offering expansion at the request of its customer base which is represented
by many leading cannabis companies in the country. Additionally, the Company
has expanded its concentrates product offering in the market to include hash
and live terp vape cartridges.
"With these new additions to
the Verse Originals and Verse Concentrates lines, Valens now has products
across all cannabis categories in the Canadian recreational market," said
Tyler Robson, Chief Executive Officer, Co-Founder and Chair of The Valens
Company. "With our proven ability to create innovative products across all
categories, we have not only increased our total addressable market in Canada,
but now hold the capability to increase partnership opportunities with our
enhanced product offering, reach more consumers with our expanded distribution
network, and elevate both the quality and value of products in the Canadian
market today."
Verse
Originals
Verse Originals dried cannabis
products are formulated using premium BC grown bud, available at an attractive
price point without sacrificing quality.
BC God
Bud Flower
Offered in a 28g pouch, the
indica-dominant flower originates from the Purple Kush lineage and features
tropical fruit flavours with undertones of berry, lavender and pine. BC God Bud
Flower is expected to be available in Alberta, British Columbia, Manitoba,
Saskatchewan and New Brunswick in the coming weeks, and Ontario in the third
quarter of 2021.
BC
Dreamweaver Pre-Rolls
Housed in a recyclable metal tin,
the 10-pack indica-dominant 0.35g pre-rolls are flavoured with hints of citrus
and tastes of fresh, earth berries from the OG Kush lineage. The BC Dreamweaver
Pre-Rolls are expected to be available in the coming weeks in Alberta, British
Columbia, Manitoba, New Brunswick and Saskatchewan, and coming to Ontario in
the third quarter of 2021.
Amp
Pre-Roll
Carefully milled, mixed and packed
for an enjoyable steady burn, the 1g Amp Pre-Roll contains a uniquely curated
blend of complementary strains with an energetic, intense and vibrant
flavouring. Each pre-roll is machine slim-rolled using proprietary technology
containing moisture sensors and a weight system to ensure product consistency,
size and shape within the manufacturing process. Packaged in a convenient,
reusable flip top single package, the Amp Pre-Roll is expected to be available
in Alberta, British Columbia and Saskatchewan in the coming weeks and coming to
Manitoba in the third quarter of 2021.
Double
Chocolate Brownie
Following the success of the Baked
Apple and Sour Medley Soft Chews introduced to the market in the first quarter
of 2021, Verse Cannabis has launched its third edible product under the Verse
Originals line, the Double Chocolate Brownie. Infused with a decadent chocolate
ganache and expertly crafted by the team at LYF Food Technologies, the 1-unit x
10mg Double Chocolate Brownie is one of the first confectionery products of its
kind to be available in the Canadian recreational market. The Double Chocolate
Brownie is expected to be available in Ontario in the third quarter of 2021 as
part of a growing selection of soft chews and confectionery products from Verse
Cannabis.
Verse
Concentrates
The Verse Concentrates premium line
of solventless concentrates continues to expand to include two new formats
created with traditional techniques to ensure exceptional quality and
remarkable consistency in the manufacturing process.
Killer
Kush Live Terp Vape Cartridge
The first to launch in a series of
Live Terp products from Verse Concentrates, the Killer Kush Live Terp Vape
Cartridge is curated using a specialized method of CO2 extraction to carefully
remove the complete terpene rich profile of fresh, flash-frozen ultra-premium
and BC sun grown Killer Kush cannabis. Through this process, the fresh live
terpene and cannabis profile of the strain is maximized, translating the
essence of the living plant into an extract comprised of exotic notes and deep
profiles. Now available in Alberta, British Columbia and Saskatchewan, the
Killer Kush Live Terp Vape Cartridge is expected to be coming soon to Ontario,
Manitoba and New Brunswick.
Hash
With a dense but pliable
consistency, Verse Hash contains a unique mix of terpenes that deliver a bold
nose of earthy, pine with light peppery undernotes. Verse Hash is offered in a
convenient 2g format packaged in a resealable pouch for freshness, and is
expected to be available in Alberta, British Columbia and Saskatchewan in the
coming weeks.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investors can trade these stocks and other ideas on our site using our list
of top stock trading apps including Robinhood , Acorn,
Stash and others.
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also available on
iTunes ( Apple Podcasts) , Audible ,
Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio , Google Play Music and most audio platforms
available.
Potcasts is now
a certified word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com -
News that Inspires Big Investing Ideas
Investorideas.com publishes breaking stock news, third party stock research , guest posts and
original articles and podcasts in
leading stock sectors. Learn about
investing in stocks and get investor
ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable
energy, gaming and more. Investor Idea’s original branded content includes
podcasts and columns : Crypto Corner , Play
by Play sports and stock news , Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast ,
Cleantech
and Climate Change , Exploring
Mining , Betting
on Gaming Stocks Podcast and the AI
Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for
iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact
Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Subscribe to:
Posts (Atom)
-
Investorideas.com - Cannabis Stock News: TransCanna (CSE: TCAN) Product Ranks in Leafly's Top Cannabis Strains List
-
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ...